Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Glucagon

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,279,970Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Mylan`s Generics Glucagon Receives Approval in US
    Mylan`s Generics Glucagon Receives Approval in US

    12 Dec 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204468

    FDA
    12 Dec 2024
    Share Share
    Abvance Gets $3.9M From Helmsley For Insulin Development
    Abvance Gets $3.9M From Helmsley For Insulin Development

    10 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/10/2943735/0/en/Abvance-Therapeutics-Announces-3-9M-Program-Related-Investment-from-the-Helmsley-Charitable-Trust-to-Support-Development-of-Its-Novel-Insulin-and-Glucagon-Combined-Formulation.html

    GLOBENEWSWIRE
    10 Sep 2024
    Share Share
    NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge
    NLS Pharmaceutics and Kadimastem Announce Binding Term Sheet to Merge

    29 Jul 2024

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=893597&lang=en

    ACCESSWIRE
    29 Jul 2024
    Share Share
    Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion
    Eli Lilly to sell low blood sugar drug to Amphastar for around $1 billion

    25 Apr 2023

    // REUTERS

    https://www.reuters.com/markets/deals/eli-lilly-sell-low-blood-sugar-drug-amphastar-2023-04-24/

    REUTERS
    25 Apr 2023
    Share Share
    Zucara Tx Publishes Preclinical Study Demonstrating ZT-01's in Type 1 Diabetes
    Zucara Tx Publishes Preclinical Study Demonstrating ZT-01's in Type 1 Diabetes

    08 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/zucara-therapeutics-announces-publication-of-preclinical-study-demonstrating-zt-01s-ability-to-restore-glucagon-release-in-type-1-diabetes-301477414.html

    PRNEWSWIRE
    08 Feb 2022
    Share Share
    Sciwind Completes Enrollment in Phase 2 Trial of XW003 in Type 2 Diabetes
    Sciwind Completes Enrollment in Phase 2 Trial of XW003 in Type 2 Diabetes

    09 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sciwind-biosciences-completes-enrollment-in-phase-2-clinical-trial-of-xw003-in-type-2-diabetes-patients-301439851.html

    PRNEWSWIRE
    09 Dec 2021
    Share Share